RIDE Act of 2019

Bill: 116-hr-3159
Sponsor: full_name: Rep. Miller, Carol D. [R-WV-3]
Introduced: 2019-06-06
Policy area: Transportation and Public Works
Subjects: Congressional oversight

Drug, alcohol, tobacco use

Government studies and investigations

Prescription drugs

Transportation safety and security
Latest action: action_date: 2019-06-07
text: Referred to the Subcommittee on Highways and Transit.

Summaries:
action_date: 2019-06-06
action_desc: Introduced in House
text: <p><b>Reinforcing Impaired Driving Education Act of 2019 or the</b> <b>RIDE Act of 2019</b></p> <p>This bill requires the National Highway Traffic Safety Administration to establish a two-year pilot program to create and study the effects of a public marketing campaign to raise awareness on driving while under the influence of prescription and over-the-counter medications. The program shall be implemented in states or territories that are most affected by the opioid epidemic.</p>

tv_txt: I 116th CONGRESS 1st Session H. R. 3159 IN THE HOUSE OF REPRESENTATIVES June 6, 2019 Mrs. Miller introduced the following bill; which was referred to the Committee on Transportation and Infrastructure A BILL To amend title 23, United States Code, to create a pilot program concerning drugged driving prevention, and for other purposes.

1. Short title This Act may be cited as the Reinforcing Impaired Driving Education Act of 2019 or the RIDE Act of 2019 . 2. Pilot program on drugged driving prevention Section 403 of title 23, United States Code, is amended by adding at the end the following: (k) Drugged driving prevention pilot program (1) In general Not later than 1 year after the date of enactment of this subsection, the Secretary of Transportation, acting through the Administrator of the National Highway Traffic Safety Administration, shall establish a pilot program to create, and study the effects of, a public marketing campaign to raise awareness on driving while under the influence of prescription and over-the-counter medications. (2) Consultation In implementing the pilot program, the Secretary may consult with pharmacies, pharmaceutical companies, and governmental and nongovernmental organizations. (3) Locations The Secretary shall implement the pilot program in States or territories that are most affected by the opioid epidemic. (4) Sunset The pilot program shall terminate on the date that is 2 years after the date on which the pilot program is established. (5) Report Not later than 1 year after the date of termination of the pilot program, the Secretary shall submit to Congress a report on the results of the study of the effects of the public marketing campaign. .